Literature DB >> 1764252

Ultraviolet radiation and the development of non-melanoma and melanoma skin cancer: clinical and experimental evidence.

M A Pathak1.   

Abstract

Clinical and experimental evidence explaining and supporting the role of UV radiation as a causal factor for the induction and promotion of nonmelanoma and malignant melanoma skin cancer are presented. While there is excellent animal experimental data and human epidemiologic evidence supporting the causal relationship of UVR (UVB, as well as UVA radiation) for basal and squamous cell carcinomas, the data establishing a direct causal relationship between melanoma and exposure to sunlight appear to be complex. They do, however, suggest a definite promotional role of sunlight in the causation of melanoma. Using a hairless pigmented mouse strain (Skh-hr2), experiments were initiated to examine the role of UVR in the induction of melanoma. A single application of DMBA as an initiator and subsequent thrice-weekly exposures to either UVB (290-320 nm) or UVA (320-400 nm) or the combined exposures of UVA and UVB resulted in the formation of blue nevus-like lesions. Repeated UVR exposures for over 30 weeks resulted in the development of melanoma (38%), as well as lymphoma and squamous cell carcinoma only in those mice that were pretreated with DMBA and had developed nevi. Mice receiving UVB, UVA, or the combination treatments of UVB plus UVA without DMBA pretreatment developed papillomas and squamous cell carcinoma but no melanoma. These studies indicate that some initiation event is essential to transform melanocytes to blue nevus-like lesions before UVR (UVB + UVA) can act as a promoter and accelerate the development of malignant melanoma, as as well as lymphoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764252     DOI: 10.1159/000210987

Source DB:  PubMed          Journal:  Skin Pharmacol        ISSN: 1011-0283


  11 in total

1.  Examination of cognitive variables relevant to sunscreen use.

Authors:  R Turrisi; J Hillhouse; C Gebert; J Grimes
Journal:  J Behav Med       Date:  1999-10

2.  Examination of cognitive variables relevant to sunbathing.

Authors:  R Turrisi; J Hillhouse; C Gebert
Journal:  J Behav Med       Date:  1998-06

3.  Predictors of sunbathing and sunscreen use in college undergraduates.

Authors:  J J Hillhouse; A W Stair; C M Adler
Journal:  J Behav Med       Date:  1996-12

4.  Application of Azjen's theory of planned behavior to predict sunbathing, tanning salon use, and sunscreen use intentions and behaviors.

Authors:  J J Hillhouse; C M Adler; J Drinnon; R Turrisi
Journal:  J Behav Med       Date:  1997-08

Review 5.  Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance.

Authors:  Chi-Ping Day; Rachel Marchalik; Glenn Merlino; Helen Michael
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

6.  Tanning, skin cancer risk, and prevention: a content analysis of eight popular magazines that target female readers, 1997-2006.

Authors:  Hyunyi Cho; Jennifer G Hall; Carin Kosmoski; Rebekah L Fox; Teresa Mastin
Journal:  Health Commun       Date:  2010-01

7.  Examination of the short-term efficacy of a parent-based intervention to prevent skin cancer.

Authors:  Rob Turrisi; Joel Hillhouse; Sarah Heavin; June Robinson; Malissa Adams; Jessica Berry
Journal:  J Behav Med       Date:  2004-08

8.  UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53.

Authors:  Nadine Chouinard; Kristoffer Valerie; Mahmoud Rouabhia; Jacques Huot
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

Review 9.  Chemoprevention of melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Adv Pharmacol       Date:  2012

10.  A Dynamic Model for Prediction of Psoriasis Management by Blue Light Irradiation.

Authors:  Zandra C Félix Garza; Joerg Liebmann; Matthias Born; Peter A J Hilbers; Natal A W van Riel
Journal:  Front Physiol       Date:  2017-01-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.